Core Insights - Eastman Chemical Company (EMN) has consistently surpassed Zacks Consensus Estimate for earnings in the last four quarters, with an average earnings surprise of approximately 7.7% [3][4] - EMN stock has increased by 9.6% over the past year, contrasting with a 1.9% decline in the wider chemical industry [4] - The upcoming fourth-quarter results are anticipated to show continued earnings growth, supported by cost-cutting measures and innovation-driven strategies [4][10] Earnings Expectations - EMN is set to release its fourth-quarter 2024 results on January 30 [2] - The Zacks Consensus Estimate for EMN's earnings in the fourth quarter is currently $1.58, with an Earnings ESP of +0.10% [6] - Revenue estimates for the upcoming quarter are pegged at $2,257 million, reflecting a year-over-year increase of about 2.3% [8] Revenue Breakdown - The Additives and Functional Products division is expected to generate revenues of $653.8 million, indicating a 2.2% year-over-year rise [8] - The Advanced Materials unit's revenues are estimated at $724 million, suggesting a 2.7% increase [8] - The Chemical Intermediates segment is projected to see revenues of $474.8 million, representing a year-over-year decline of 7.5% [9] - The Fiber segment is expected to achieve revenues of $366.8 million, indicating a 6% year-over-year increase [9] Factors Influencing Performance - Cost-cutting initiatives and operational transformation efforts are anticipated to lower operating costs and enhance profitability [10] - Pricing strategies and reduced raw material and energy costs are expected to support EMN's bottom line in the fourth quarter [10] - Innovation and market development initiatives are likely to boost sales volumes, particularly in key end markets [11] Market Demand Challenges - EMN faces challenges from weak demand in specific markets, particularly in building & construction and consumer durables [12] - The company is experiencing soft demand in building & construction across most regions, which may adversely impact performance [12][13] - While customer inventory de-stocking is ending in most markets, it is expected to persist in medical applications during the fourth quarter [13]

Group 1 - The article discusses the author's long position in BASFY and EMN shares, indicating a positive outlook on these companies [1] - The author emphasizes the importance of conducting due diligence and research before making investment decisions, highlighting the risks associated with short-term trading and options trading [2] - The article clarifies that past performance is not indicative of future results and that the views expressed may not represent the opinions of Seeking Alpha as a whole [3]

Project Development - Euro Manganese Inc's subsidiary, Mangan Chvaletice, has secured the Determination of Mining Lease permit, marking a critical milestone for the Chvaletice Manganese Project in the Czech Republic [1] - The permit, effective from 23 January 2025, grants exclusive and unrestricted rights to mineral extraction within the designated area, with no expiration date, ensuring robust legal protection for the project [2] - The permit replaces all prior authorizations and enables the company to proceed with the next phases of the project on an exclusive basis [2] Strategic Importance - The Chvaletice Project is the only sizable manganese resource in the European Union, positioning the company strategically to support the global shift to a circular, low-carbon economy [5] - The project involves reprocessing old tailings from a decommissioned mine, offering a unique waste-to-value recycling and remediation opportunity [5] - High-purity manganese produced by the project is essential for the transition to a greener economy and the global effort to decarbonize [3] Company Overview - Euro Manganese is a battery materials company focused on becoming a leading producer of high-purity manganese for the electric vehicle industry [4] - The company is advancing the Chvaletice Manganese Project in the Czech Republic and exploring an early-stage opportunity to produce battery-grade manganese products in Bécancour, Québec [4] - Euro Manganese is dual-listed on the TSXV and the ASX and is also traded on the OTCQX [5] Leadership and Collaboration - Martina Blahova, Interim CEO of Euro Manganese, emphasized the significance of the Mining Lease permit, highlighting successful collaboration with federal and regional regulators and host communities [3] - The permit underscores a shared commitment to the project's progress and brings the company closer to establishing a commercial-scale facility for high-purity manganese production [3]

Core Viewpoint - Eastman Chemical is expected to report a year-over-year increase in earnings and revenues, with the stock price likely influenced by how actual results compare to consensus estimates [1][3]. Earnings Expectations - The upcoming earnings report is anticipated to show earnings of $1.58 per share, reflecting a +20.6% change year-over-year, and revenues of $2.26 billion, which is a 2.3% increase from the previous year [3]. - The consensus EPS estimate has been revised 1.74% lower in the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates a positive Earnings ESP of +0.10% for Eastman Chemical, suggesting a potential earnings beat, although the stock has a Zacks Rank of 4, complicating predictions [10][11]. - Historically, Eastman Chemical has beaten consensus EPS estimates in the last four quarters, with a +6.10% surprise in the most recent quarter [12][13]. Market Reaction Factors - The stock's movement will depend on the actual earnings results compared to expectations, as well as management's commentary on business conditions during the earnings call [2][14]. - An earnings beat does not guarantee a stock price increase, as other factors may influence investor sentiment [14][16].

Core Viewpoint - Eastman Chemical Company is positioned to benefit from innovation and cost-cutting measures despite facing demand weakness in certain markets [1][2]. Group 1: Company Performance - EMN stock has decreased by 10.7% over the past six months, slightly better than the Zacks Chemicals Diversified industry's decline of 11.3% [2]. - The company anticipates an incremental EBITDA contribution of $20-$30 million from its Kingsport methanolysis facility for the full year 2024 [5]. - Eastman Chemical is expected to generate around $1.3 billion in operating cash flow for the full year 2024 [8]. Group 2: Innovation and Growth Strategy - Eastman aims to boost new business revenues through an innovation-driven growth strategy, focusing on sales growth in key end markets such as consumer durables, building & construction, and transportation [4]. - The company is implementing operational transformation programs to manage costs effectively, including maintaining pricing discipline and improving asset utilization [7]. Group 3: Dividend and Capital Allocation - Eastman Chemical has increased its quarterly cash dividend to 83 cents per share, marking the 15th consecutive year of dividend hikes, reflecting confidence in steady earnings and strong cash flow [8]. - The company plans to repurchase shares worth approximately $300 million in 2024 [8]. Group 4: Market Challenges - Eastman Chemical is experiencing weak demand in specific markets, particularly in building & construction and consumer durables, with sluggish demand noted across most regions [9]. - The company expects continued inventory de-stocking in medical applications, which may adversely affect performance in the fourth quarter of 2024 [10].

Core Viewpoint - Eastman Chemical Company (EMN) is experiencing growth driven by innovation and cost management despite facing demand weaknesses in certain markets [1][3]. Group 1: Innovation and Growth Strategy - Eastman is focusing on increasing new business revenues through an innovation-driven growth strategy, which is expected to enhance sales volumes [3]. - The company's specialty portfolio is projected to drive sales growth in key end markets such as consumer durables, building & construction, and transportation [3]. Group 2: Financial Performance and Cost Management - The Kingsport methanolysis facility is anticipated to contribute an incremental EBITDA of $20-$30 million year-over-year in 2024 [4]. - Eastman achieved cost savings of approximately $200 million in 2023, net of inflation, and is expected to benefit from lower operating costs due to its operational transformation program in 2024 [5]. - The company plans to maintain pricing discipline and improve asset utilization throughout 2024 [5]. Group 3: Capital Allocation and Shareholder Returns - Eastman is committed to disciplined capital allocation with a focus on debt reduction, returning $526 million to shareholders in 2023 through dividends and share repurchases [6]. - The company raised its dividend for the 14th consecutive year and plans to repurchase shares worth around $300 million in 2024 [7]. - EMN expects to generate approximately $1.3 billion in operating cash flow in 2024 [7]. Group 4: Demand Challenges - Eastman is facing challenges from weak demand in specific markets, particularly in building & construction and cautious customer behavior in consumer durables and electronics [8]. - The company anticipates continued weak demand in medical applications, which may adversely affect performance in the fourth quarter of 2024 [9].

Group 1: Investment and Expansion - Eastman Chemical Company (EMN) will invest in upgrading and expanding its extrusion capability for Interlayers product lines at its Ghent, Belgium manufacturing site, enhancing supply capacity for Saflex polyvinyl butyral (PVB) products in the Automotive Premiums sector [1] - The project is expected to be completed by 2026, positioning Eastman for future growth in automotive and architecture segments [1] Group 2: Market Trends and Demand - Strong macrotrends in expanding connectivity, autonomous driving, and electrification are driving demand for Eastman's Automotive Premium products, including Saflex Horizon Vision for head-up displays and Evoca RSL for electric vehicles [2] - This investment supports the company's innovation-driven growth strategy and provides service differentiation to clients [2] Group 3: Product Features and Financial Performance - Saflex interlayers, made of PVB films laminated between glass sheets, improve automotive and architectural glass lamination through solar management, noise reduction, safety, security, and ultraviolet protection [3] - Eastman Chemical's shares have surged 27% over the past year, compared to the industry's 1.1% rise [3] - The company expects earnings per share for 2024 to be between $7.50 and $7.70, with operating cash flow projected to total $1.3 billion [3] Group 4: Seasonal Trends and Growth Strategy - Eastman anticipates normal seasonal volume declines across most end markets in the fourth quarter but plans to leverage its innovation-driven growth model to drive growth [4]

Eastman Chemical Company (NYSE:EMN) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Greg Riddle - IR Mark Costa - Board Chair and CEO William McLain - EVP and CFO Conference Call Participants David Begleiter - Deutsche Bank Patrick Cunningham - Citigroup Duffy Fischer - Goldman Sachs Frank Mitsch - Fermium Research Vincent Andrews - Morgan Stanley Michael Leithead - Barclays Josh Spector - UBS Jeff Zekauskas - JPMorgan Aleksey Yefremov - KeyCorp Mike Sison - Wells Fargo Kev ...

Table of Contents EASTMAN UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission file number 1-12626 EASTMAN CHEMICAL COMPANY (Exact name of registrant as specified in ...

Eastman Chemical Company (EMN) logged earnings (as reported) of $1.53 per share compared with $1.49 in the year-ago quarter. Barring one-time items, earnings were $2.26 per share, up from $1.47 in the year-ago quarter. It surpassed the Zacks Consensus Estimate of $2.13.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Revenues increased roughly 9% year over year to $2,464 million in the quarter. The figure beat the Zacks Consensus Estimate of $2,394.2 million. EMN saw higher sales volum ...